Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 févr. 2021 14h06 HE | Source: Bragar Eagel & Squire

AKERS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of AKER and Encourages Investors to Contact the Firm

NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
09 août 2018 18h06 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PG&E, Akers Biosciences, and UNUM and Encourages Investors to Contact the Firm

NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of PG&E Corporation, Akers...
12 juil. 2018 19h56 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PG&E Corporation, Akers Biosciences, Inc., and UNUM Group and Encourages Investors to Contact the Firm

NEW YORK, July 12, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that class action lawsuits have been commenced on behalf of shareholders of PG&E Corporation, Akers...
14 sept. 2015 07h00 HE | Source: Akers Biosciences Inc.

Akers Biosciences Launches METRON(R) - the First and Only Disposable Breath Ketone Test

THOROFARE, N.J., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of...